{
    "2020-06-05": [
        [
            {
                "time": "2020-06-15",
                "original_text": "Hope dims for hydroxychloroquine even as medical study detailing the drugâ€™s failure is retracted",
                "features": {
                    "keywords": [
                        "hydroxychloroquine",
                        "medical study",
                        "failure",
                        "retracted"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Novartis' Asthma Treatment Meets Primary Endpoint in Phase III",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Asthma Treatment",
                        "Phase III",
                        "Primary Endpoint"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals",
                "features": {
                    "keywords": [
                        "LLY",
                        "Coronavirus Antibody",
                        "Phase I",
                        "FDA Approvals"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-15",
                "original_text": "The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",
                "features": {
                    "keywords": [
                        "Adamas",
                        "FDA Acceptance",
                        "Oxford Immunotech",
                        "$400M Bid"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}